4//SEC Filing
SGX PHARMACEUTICALS, INC. 4
Accession 0001350091-07-000010
CIK 0001125603operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 3:44 PM ET
Size
8.8 KB
Accession
0001350091-07-000010
Insider Transaction Report
Form 4
Myers W Todd
CFO
Transactions
- Exercise/Conversion
Common Stock
2007-06-05+1,563→ 14,845 total - Exercise/Conversion
Restricted Stock Units
2007-06-05−1,563→ 46,875 total→ Common Stock (1,563 underlying) - Sale
Common Stock
2007-06-05$5.30/sh−781$4,139→ 14,064 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2006.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]25% of the restricted stock units vested on December 5, 2006. The remaining restricted stock units vest in equal monthly installments over the subsequent 3 years until December 5, 2009.
Documents
Issuer
SGX PHARMACEUTICALS, INC.
CIK 0001125603
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001125603
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 3:44 PM ET
- Size
- 8.8 KB